Feb 14 (Reuters)-
Cosmo Bio Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Dec 31, 2024 Dec 31, 2023 Dec 31, 2025 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 10.04 9.34 10.70 5.50
(+7.5 pct) (-2.2 pct) (+6.6 pct) (+7.2 pct)
Operating 318 mln 519 mln 490 mln 290 mln
(-38.7 pct) (-36.3 pct) (+53.8 pct) (-10.2 pct)
Recurring 364 mln 653 mln 580 mln 360 mln
(-44.2 pct) (-17.4 pct) (+59.2 pct) (+6.7 pct)
Net
Net 262 mln 442 mln 430 mln 280 mln
(-40.8 pct) (-14.4 pct) (+64.1 pct) (+8.4 pct)
EPS 45.05 yen 75.97 yen 75.04 yen 48.86 yen
Ann Div 50.00 yen 30.00 yen 50.00 yen
-Q2 Div 14.00 yen 14.00 yen 25.00 yen
-Q4 Div 36.00 yen 16.00 yen 25.00 yen
NOTE - Cosmo Bio Co Ltd.
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3386.T